Korean Journal of Radiology

  • 제22권12호
  • /
  • Pages.2124-2126
  • /
  • 2021
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma

  • Arwa Ashoor (Department of Breast Surgery, Sandwell and West Birmingham NHS Trust, City Hospital Birmingham) ;
  • Julie Shephard (Department of Breast Radiology, Sandwell and West Birmingham NHS Trust, City Hospital Birmingham) ;
  • Germana Lissidini (Division of Breast Surgery, European Institute of Oncology, IRCCS) ;
  • Luca Nicosia (Division of Breast Surgery, Breast Radiology, European Institute of Oncology, IRCCS)
  • 투고 : 2021.08.23
  • 심사 : 2021.10.19
  • 발행 : 2021.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Studdiford J, Lamb K, Horvath K, Altshuler M, Stonehouse A. Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination. Pharmacotherapy 2008;28:1194-1197 
  2. Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean J Radiol 2021;22:1938-1945 
  3. Grimm L, Destounis S, Dogan B, Nicholson B, Dontchos B, Sonnenblick E, et al. SBI recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination. Reston: Society of Breast Imaging, 1891 
  4. Centers for Disease Control and Prevention. The Moderna COVID-19 vaccine's local reactions, systemic reactions, adverse events, and serious adverse events. cdc.gov Web site. https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html. Accessed January 16, 2021 
  5. Centers for Disease Control and Prevention. Pfizer-BioNTech COVID-19 vaccine reactions & adverse events. cdc.gov Web site. https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html. Accessed January 16, 2021 
  6. Ozutemiz C, Krystosek LA, Church AL, Chauhan A, Ellermann JM, Domingo-Musibay E, et al. Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology 2021;300:E296-E300 
  7. Mehta N, Sales RM, Babagbemi K, Levy AD, McGrath AL, Drotman M, et al. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine. Clin Imaging 2021;75:12-15 
  8. The Royal College of Radiologists. Guidance on screening and symptomatic breast imaging, fourth edition. rcr.ac.uk Web site. https://www.rcr.ac.uk/publication/guidance-screening-and-symptomatic-breast-imaging-fourth-edition. Accessed March 23, 2021 
  9. Lee SH, Yi A, Jang MJ, Chang JM, Cho N, Moon WK. Supplemental screening breast US in women with negative mammographic findings: effect of routine axillary scanning. Radiology 2018;286:830-837 
  10. Lernevall A. Imaging of axillary lymph nodes. Acta Oncol 2000;39:277-281 
  11. Dialani V, James DF, Slanetz PJ. A practical approach to imaging the axilla. Insights Imaging 2015;6:217-2 
  12. Ogiya A, Kimura K, Nakashima E, Sakai T, Miyagi Y, Iijima K, et al. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital. Breast Cancer 2016;23:318-322 
  13. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338:327-331 
  14. Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006;24:2028-2037